IL17A and osteoporosis: Research involving osteoporosis models, particularly in mice that have undergone ovariectomy—a procedure that simulates post-menopausal osteoporosis in humans—demonstrates that antibodies neutralizing IL-17 can effectively slow down or inhibit the progression of bone loss [98].